These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 32203306)

  • 1. Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers.
    Maia MC; Salgia M; Pal SK
    Nat Rev Urol; 2020 May; 17(5):271-291. PubMed ID: 32203306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
    Lin SY; Linehan JA; Wilson TG; Hoon DSB
    Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer.
    Chen H; Xu C; Fang Z; Mao S
    Methods Mol Biol; 2023; 2695():165-179. PubMed ID: 37450118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.
    Christensen E; Birkenkamp-Demtröder K; Sethi H; Shchegrova S; Salari R; Nordentoft I; Wu HT; Knudsen M; Lamy P; Lindskrog SV; Taber A; Balcioglu M; Vang S; Assaf Z; Sharma S; Tin AS; Srinivasan R; Hafez D; Reinert T; Navarro S; Olson A; Ram R; Dashner S; Rabinowitz M; Billings P; Sigurjonsson S; Andersen CL; Swenerton R; Aleshin A; Zimmermann B; Agerbæk M; Lin CJ; Jensen JB; Dyrskjøt L
    J Clin Oncol; 2019 Jun; 37(18):1547-1557. PubMed ID: 31059311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.
    Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S
    BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
    Birkenkamp-Demtröder K; Nordentoft I; Christensen E; Høyer S; Reinert T; Vang S; Borre M; Agerbæk M; Jensen JB; Ørntoft TF; Dyrskjøt L
    Eur Urol; 2016 Jul; 70(1):75-82. PubMed ID: 26803478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
    Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
    Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA in cancer: current insights.
    Fettke H; Kwan EM; Azad AA
    Cell Oncol (Dordr); 2019 Feb; 42(1):13-28. PubMed ID: 30367445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
    Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC
    BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis.
    Birkenkamp-Demtröder K; Christensen E; Nordentoft I; Knudsen M; Taber A; Høyer S; Lamy P; Agerbæk M; Jensen JB; Dyrskjøt L
    Eur Urol; 2018 Apr; 73(4):535-540. PubMed ID: 28958829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay.
    Fettke H; Steen JA; Kwan EM; Bukczynska P; Keerthikumar S; Goode D; Docanto M; Ng N; Martelotto L; Hauser C; Southey MC; Azad AA; Nguyen-Dumont T
    Biotechniques; 2020 Aug; 69(2):133-140. PubMed ID: 32654508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective capture of plasma cell-free tumor DNA on magnetic beads: a sensitive and versatile tool for liquid biopsy.
    Kerachian MA; Azghandi M; Javadmanesh A; Ghaffarzadegan K; Mozaffari-Jovin S
    Cell Oncol (Dordr); 2020 Oct; 43(5):949-956. PubMed ID: 32495293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Treatment Stratification Using ctDNA.
    Vidal J; Taus A; Montagut C
    Recent Results Cancer Res; 2020; 215():263-273. PubMed ID: 31605234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression.
    Lau E; McCoy P; Reeves F; Chow K; Clarkson M; Kwan EM; Packwood K; Northen H; He M; Kingsbury Z; Mangiola S; Kerger M; Furrer MA; Crowe H; Costello AJ; McBride DJ; Ross MT; Pope B; Hovens CM; Corcoran NM
    Genome Med; 2020 Aug; 12(1):72. PubMed ID: 32807235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating cell-free tumor DNA analysis in pediatric cancers.
    Andersson D; Fagman H; Dalin MG; Ståhlberg A
    Mol Aspects Med; 2020 Apr; 72():100819. PubMed ID: 31563277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.
    Gašperšič J; Videtič Paska A
    Biochem Med (Zagreb); 2020 Oct; 30(3):030504. PubMed ID: 32774122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy and minimal residual disease - latest advances and implications for cure.
    Pantel K; Alix-Panabières C
    Nat Rev Clin Oncol; 2019 Jul; 16(7):409-424. PubMed ID: 30796368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].
    Haupts A; Roth W; Hartmann N
    Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.